Cargando…
The pretubulysin-induced exposure of collagen is caused by endothelial cell retraction that results in an increased adhesion and decreased transmigration of tumor cells
Microtubule-targeting agents (MTAs) are the most widely used chemotherapeutic drugs. Pretubulysin (PT), a biosynthetic precursor of the myxobacterial tubulysins, was recently identified as a novel MTA. Besides its strong anti-tumoral activities, PT attenuates tumor angiogenesis, exerts anti-vascular...
Autores principales: | Schwenk, Rebecca, Stehning, Tanja, Bischoff, Iris, Ullrich, Angelika, Kazmaier, Uli, Fürst, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652804/ https://www.ncbi.nlm.nih.gov/pubmed/29100413 http://dx.doi.org/10.18632/oncotarget.20746 |
Ejemplares similares
-
Combined antitumoral effects of pretubulysin and methotrexate
por: Kern, Sarah, et al.
Publicado: (2019) -
Pretubulysin: From Hypothetical Biosynthetic Intermediate to Potential Lead in Tumor Therapy
por: Herrmann, Jennifer, et al.
Publicado: (2012) -
The Microtubule-Targeting Agent Pretubulysin Impairs the Inflammatory Response in Endothelial Cells by a JNK-Dependent Deregulation of the Histone Acetyltransferase Brd4
por: Primke, Tobias F., et al.
Publicado: (2023) -
Pretubulysin: a new option for the treatment of metastatic cancer
por: Braig, S, et al.
Publicado: (2014) -
The vacuolar-type ATPase inhibitor archazolid increases tumor cell adhesion to endothelial cells by accumulating extracellular collagen
por: Luong, Betty, et al.
Publicado: (2018)